Literature DB >> 8824241

Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism.

M C Krishna1, A Samuni, J Taira, S Goldstein, J B Mitchell, A Russo.   

Abstract

The ability of stable nitroxide radicals to detoxify hypervalent heme proteins such as ferrylmyoglobin (MbFeIV) produced in the reaction of metmyoglobin (MbFeIII) and H2O2 was evaluated by monitoring O2 evolution, H2O2 depletion, and redox changes of the heme prosthetic group. The rate of H2O2 depletion and O2 evolution catalyzed by MbFeIII was enhanced by stable nitroxides such as 4-OH-2,2,6,6-tetramethyl-piperidinoxyl (TPL) in a catalytic fashion. The reduction of MbFeIV to MbFeIII was the rate-limiting step. Excess TPL over MbFeIII enhanced catalase-like activity more than 4-fold. During dismutation of H2O2, [TPL] and [MbFeIV] remained constant. NADH caused: (a) inhibition of H2O2 decay; (b) progressive reduction of TPL to its respective hydroxylamine TPL-H; and (c) arrest/inhibition of oxygen evolution or elicit consumption of O2. Following depletion of NADH the evolution of O2 resumed, and the initial concentration of TPL was restored. Kinetic analysis showed that two distinct forms of MbFeIV might be involved in the process. In summary, by shuttling between two oxidation states, namely nitroxide and oxoammonium cation, stable nitroxides enhance the catalase mimic activity of MbFeIII, thus facilitating H2O2 dismutation accompanied by O2 evolution and providing protection against hypervalent heme proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824241     DOI: 10.1074/jbc.271.42.26018

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism.

Authors:  Paul W Buehler; Jin Hyen Baek; Christina Lisk; Ian Connor; Tim Sullivan; Douglas Kominsky; Susan Majka; Kurt R Stenmark; Eva Nozik-Grayck; Joe Bonaventura; David C Irwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-22       Impact factor: 5.464

Review 2.  Mitochondria as a target in treatment.

Authors:  Marie-Céline Frantz; Peter Wipf
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

3.  The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.

Authors:  Christine H J Kim; James B Mitchell; Christina A Bursill; Anastasia L Sowers; Angela Thetford; John A Cook; David M van Reyk; Michael J Davies
Journal:  Atherosclerosis       Date:  2015-03-16       Impact factor: 5.162

4.  The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation.

Authors:  Yuval Samuni; Wilmarie Flores-Santana; Murali C Krishna; James B Mitchell; David A Wink
Journal:  Free Radic Biol Med       Date:  2009-05-15       Impact factor: 7.376

5.  Spin scavenging analysis of myoglobin protein-centered radicals using stable nitroxide radicals: characterization of oxoammonium cation-induced modifications.

Authors:  Olivier M Lardinois; David A Maltby; Katalin F Medzihradszky; Paul R Ortiz de Montellano; Kenneth B Tomer; Ronald P Mason; Leesa J Deterding
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

6.  Antioxidant properties of MitoTEMPOL and its hydroxylamine.

Authors:  Jan Trnka; Frances H Blaikie; Angela Logan; Robin A J Smith; Michael P Murphy
Journal:  Free Radic Res       Date:  2009-01

7.  2,2-Diphenyl-benzo[c]quinoline-1-ox-yl.

Authors:  Corrado Rizzoli; Elda Marku; Lucedio Greci; Paola Astolfi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-04-18

Review 8.  Heme degradation and vascular injury.

Authors:  John D Belcher; Joan D Beckman; Gyorgy Balla; Jozsef Balla; Gregory Vercellotti
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

9.  Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent.

Authors:  Fuminori Hyodo; Kai-Hsiang Chuang; Artem G Goloshevsky; Agnieszka Sulima; Gary L Griffiths; James B Mitchell; Alan P Koretsky; Murali C Krishna
Journal:  J Cereb Blood Flow Metab       Date:  2008-02-13       Impact factor: 6.200

10.  Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI.

Authors:  Fuminori Hyodo; Ramachandran Murugesan; Ken-ichiro Matsumoto; Emi Hyodo; Sankaran Subramanian; James B Mitchell; Murali C Krishna
Journal:  J Magn Reson       Date:  2007-10-30       Impact factor: 2.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.